Gagnon Robert E. 4
4 · Bone Biologics Corp · Filed Sep 19, 2024
Insider Transaction Report
Form 4
Gagnon Robert E.
Director
Transactions
- Award
Non- Employee Stock Option
2024-09-17+30,713→ 30,713 totalExercise: $1.73Exp: 2034-09-17→ Common Stock (30,713 underlying)
Holdings
- 9
Non- Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (9 underlying) - 8,006
Non- Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (8,006 underlying)
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company.
- [F2]This option is fully exercisable as of the date of this report.